Green Synthesis of Silver Nanoparticles: Exploring Characterization Studies and Biological Activity


Angel Mary Jane J. S1*, R. Murali2, Deepthi B.V1 and Aathira W.V1 and Ajina W.S1

1Department of Chemistry, Affiliated to Manonmaniam Sundaranar University, Abishekapatti, Tirunelveli, Tamil Nadu, India.

2Department of Chemistry, Nanjil Catholic College of Arts and Science, Kaliyakkavilai, Tamil Nadu, India.

Corresponding Author E-Mail: jsangelmaryjane@gmail.com

Download this article as: 

ABSTRACT:

Several techniques can be used to create silver nanoparticles (AgNPs) with antibacterial activity and spectrum behaviour. The green synthesis approach can be applied in this study. Silver nanoparticles can be made from betel leaf extract. Among other things, this extract can help with wound healing, digestive support, and oral health. Moreover, this study also makes use of cinnamic acid. When creating silver nanoparticles, cinnamic acid has been employed as a protective ligand and reducing agent. This research,included UV-visible, FT-IR, XRD, SEM, and EDAX spectra, was used to characterize the synthesized AgNPs. Two gram-positive and two gram-negative bacteria were used to evaluate the antibacterial activity. Because of the antimicrobial and dermatological qualities of organic molecules derived from plants, AgNPs made through green synthesis using medicinal plants are used to promote wound healing.

KEYWORDS:

Antimicrobial; EDAX; FT-IR; SEM; Silver Nanoparticles; XRD

Introduction

Due to their prospective uses as antibacterial and biocidal agents in wound care, orthopaedic implants, food preservation, protective apparel, and cosmetics, silver nanoparticles have drawn a lot of attention recently.1–14 One of the most valuable and noble metals is silver.  Ag nanoparticles’ broad antibacterial spectrum and high biocidal effectiveness make them a powerful antimicrobial agent. Moreover, the problem of bacterial resistance, which is addressed by widely used antibiotics in the fight against bacterial infections for biomedical applications, may be solved using Ag nanoparticles. Ag nanoparticles’ efficacy against a wide range of harmful bacteria and fungi is linked to environmental toxicity. With the formula C6H5CH=CHCOOH, cinnamic acid is an aromatic carboxylic acid that is found naturally in plants. Cinnamic acid, which is generated from ester derivatives, has a wide range of biological activities, including antibacterial and anticancer properties, low in toxicity.15-21 Since it is the most effective lipoxygenase inhibitor, it is also employed in medication development.

As silver discovers new applications, especially in the medical, plastic, and textile sectors, as well as in surgical and dental instruments, coated water filters, sanitisers, detergents, soap, and wound dressings, the silver market is anticipated to grow.22-29 As they spread throughout the global economy, these items and technologies are altering the pattern of silver emission because they are used in healthcare to treat mental illness, convulsions, drug addiction, and sexually transmitted diseases like gonorrhoea and syphilis.30-39 Usually ranging in size from 1 to 100 nm, AgNPs are silver nanoparticles with unique electrical, optical, and magnetic properties that have a wide range of uses.40 Biotechnology is a novel approach to biological AgNPs production. Furthermore, due to their larger surface area, magnetic nanoparticles have a lot of antibacterial potential and can be utilised to treat increased microbial resistance to a range of medications and antibiotics.41-49

Since the green synthesis process is extremely environmentally friendly, we are using it in this study to create silver nanoparticles. This concept is highly helpful for reducing the material in both ecological and economic processes. Identify the absorbance wavelength and functional grouping that are present in the nanoparticles using the UV-visible and FTIR spectroscopy experiments. The presence of AgNPs has been confirmed by SEM, XRD, and EDAX tests. Additionally, determine the synthesized nanoparticle’s antibacterial activity in this study. Cinnamic acid has been investigated for the synthesis of AgNPs to increase the antibacterial activity of Ag nanomaterials while minimizing their toxicity.

Materials and Methods

Silver nitrate and cinnamic acid were acquired from Sigma Chemical Company in Kanyakumari, Tamil Nadu. The suppliers of all the other chemicals were Labchem Products in Chennai, Tamil Nadu.

Preparation of AgNPs

A 50 mL flask with a round bottom was filled with 0.0282g of pure cinnamic acid. For 15 minutes, 50 mL of pure distilled water and cinnamic acid are combined in a water bath set at 50°C. The solution will be fully dissolved after fifteen minutes. A 50 mL volumetric flask was filled with the dissolved solution. 0.1g of AgNO3 solution should be added, along with betel leaf extract. Concentrated ammonia is added to this solution to bring its pH down to 9.0. This solution was poured into an autoclave lined with Teflon, which was then placed in an oven set to 140°C for four hours. The yield from the reaction will be used for additional research.50-57

Characterization studies

In the characterization study,UV, FTIR,XRD, SEM and EDAX technique were used.

Results and Discussions

UV-visible Spectroscopy

A very practical and trustworthy method for the initial characterisation of synthesised nanoparticles, this spectroscopy is also utilized to track the stability and synthesis of AgNPs. Using a Shimadzu-UV 1800 UV-visible spectrometer, the absorbance spectra of the colloidal sample was obtained in the 200–800 nm region. UV-vis spectroscopy is also used for the colloidal suspensions of synthesized nanoparticles.58-63 AgNPs absorption is influenced by the chemical environment, dielectric medium, and particle size. According to the UV absorption data, the 0.01M solution of cinnamic acid utilising AgNPs showed a high absorption band peak at 300–350 nm.

Figure 1: UV-visible absorption Spectrum of Synthesized AgNPs

Click here to View Figure

FT-IR Spectroscopy

The generation of very pure AgNPs was confirmed by FTIR analysis of green synthesised AgNPs, which showed a powerfulband at 1386 cm-1and peaks at 563 cm-1that can be attributed to Ag vibrations. The existence of –OH, C–C, and C=O stretching of hydroxyl groupslikealkenes, and alkanes are indicated by the bands at approximately 3296, 1698, and 2377 cm-1, respectively. The stretching of the carboxyl groups is responsible for the significant absorption at 1698cm-1, and the stretching of the aromatic ring’s C=C group was proved by the absorption bands at 1698cm-1, 1574 cm-1, and 1558cm-1. As the absorption strength increases, the adsorption band in the CA-AgNPs FTIR spectra that corresponds to the hydroxyl stretching shifts to 3296cm-1. Furthermore, the carboxyl groups’ corresponding adsorption band shifts to 1698cm-1. These findings demonstrated that the cinnamic acid carboxyl groups were present on the AgNPs’ surface and that they interacted strongly with the Ag atoms there.64-71

Figure 2: FTIR Spectrum of synthesized Silver Nanoparticles

Click here to View Figure

XRD Spectroscopy

Powder XRD is used to characterise the nanoparticles created using this process to verify that they are silver and to determine their structural details. The synthesised nanoparticle’s XRD spectrum is displayed in Figure 3. The (110), (-111), (200), (−202), (020), (202), (−113), and (022) planes were identified as the respective intensity peaks at 2θ of 32.82, 35.72, 38.50, 48.27, 53.95, 58.41, 61.95, and 66.07, according to XRD analysis.72-77 No further phases were detected, and all of the intensity peaks potentially classified as typical monoclinic in structure. JCPDS card no. 801268 verified that the peak positions showed the monoclinic structure of AgNPs.

Figure 3: XRD Spectrum of AgNPs

Click here to View Figure

Scanning Electron Microscope

SEM was used to examine the shape and surface structure of the produced AgNPs; the resulting micrograph is displayed in Fig. 4. ImageJ software was used to determine the average particle size, which came out to be 59.99 nm.78-80

Figure 4: SEM image of synthesized AgNPs

Click here to View Figure

Energy Dispersive X-Ray (EDAX/EDX) Technique

Three peaks that are closely associated with Ag in the tested material are shown in the EDAX/EDX studies of Figure 5. According to the data, the reaction product is made up of very pure CA-AgNPs, which is consistent with the XRD result (Figure 4). Ag (76.63%) and Cl (23.37%) were the weight compositions determined by EDAX/EDX analysis of the normalised spectra. Nonstoichiometric CA-AgNP synthesis was also detected by EDAX/EDX.81-84

Figure 5: EDAX image of synthesized AgNPs

Click here to View Figure

Antimicrobial Activity

By the report of (NCCLS), the agar used disc diffusion method was used to examine the samples’ antibacterial activity. The following table displays the results. The antibacterial efficacy of biologically produced CA-AgNPs against Escherichia coli is demonstrated in Figure 4. However, the study revealed that compared to Staphylococcus aureus and Bacillus cereus (Gram-positive bacteria), Escherichia coli and Pseudomonas aeruginosa (Gram-negative bacteria) were less sensitive to antibiotics and antibacterial agents. The effects are more noticeable when gram-positive bacteria (Bacillus cereus) have an inhibition diameter of 16 mm and gram-negative bacteria (Pseudomonas aeruginosa) have an inhibition diameter of 18 mm.85

Two different types of bacteria were effectively inhibited the CA-AgNPs. However, compared to Gram-positive Staphylococcus aureus, it had greater antibacterial action againstE coli and P aeruginosa. Gram-positive bacterial strains were less sensitive to the biosynthesized CA AgNPs than Gram-negative strains, according to the study’s findings.86 Therefore, adding antibacterial Ag NPs to the aforementioned nanoparticle can help with several biomedical uses as well as environmental remediation, particularly in wastewater treatment. Table 1 and Figure 6 both referenced the antibacterial activity results.

Table 1: Antimicrobial activity results for synthesized AgNPs

Sample

E coli P aeruginosa S aureus B cereus
CA-AgNPs 13 18 13

16

Antibiotics

30 23 34

30

 

Figure 6: Antimicrobial activity results for synthesized AgNPs

Click here to View Figure

Conclusion

UV, FTIR, XRD, SEM, EDAX, and antibacterial activity were used to characterise the synthesised AgNPs. The findings showed that the discussion section provides a detailed explanation of the generated AgNPs capped by cinnamic acid. AgNPs inhibited Pseudomonas aeruginosa and Staphylococcus aureus, according to antimicrobial testing. It is anticipated that the AgNPs produced in this investigation will become effective antibacterial agents. The process is simple to follow in any laboratory setting, the use of harmful reagents is eliminated, and the study is pollution-free, readily available, affordable, and environmentally beneficial.

Acknowledgement

The authors are thankful to Nanjil Catholic College, Kaliyakavilai, Kanyakumari India and Manonmaniam Sundaranar University, Tirunelveli, India for furnishing necessary provision and support for this work.

Funding Sources

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Conflict of Interest

The author(s) do not have any conflict of interest.

Data Availability Statement

This statement does not apply to this article.

Ethical approval

When preparing this article, we perform the experiments contain UV, FTIR, XRD, SEM, EDAX instrumentations and antibacterial activity.

Author’s Contribution

The authors (Angel Mary Jane J. S, Dr. R. Muraliand Deepthi B V) have contributed equally to writing and reviewing the manuscript.

References

  1. Klaus, T.J., Proc Natl Acad Sci USA, 1999, 96, 13611-13614.
    CrossRef
  2. Chernousova, S., Chem. Int. Ed, 2013, 52, 1636–1653.
    CrossRef
  3. Congcong., Nanocomposites,2012, 15, 95-101.
  4. Wilkinson LJ., J Wound Care, 2011, 20, 543–549.
    CrossRef
  5. Saravanan M., Elsevier, 2021, 12, 101–122.
    CrossRef
  6. Gurunathan., Int. J. Nanomed, 2015, 10, 2951–2969.
    CrossRef
  7. Sapsford., Anal. Chem, 2011, 83, 4453–4488.
    CrossRef
  8. Sergeev., Mendeleev Commun, 1999, 4, 130–132.
    CrossRef
  9. Mafuné,F., Phys. Chem. B2000, 104, 9111–9117.
    CrossRef
  10. Hulteen., J. Phys. Chem. B1999, 103, 3854–3863.
    CrossRef
  11. Zhu., Mater. Lett. 2001, 49, 91–95.
    CrossRef
  12. Abid, Commun. 2002, 7, 792–793.
    CrossRef
  13. Talebi, J. J. Sci. 2010, 45, 3318–3324.
    CrossRef
  14. Hosseinpou. Mater. Lett.2014, 130, 259–262.
    CrossRef
  15. Zhang, J. Am. Chem. Soc. 2011, 133, 18931–18939.
    CrossRef
  16. Ganaie, S.U Technol. 2015, 33, 638–644.
    CrossRef
  17. Carlson, C. J. Phys. Chem. B2008, 112, 13608–13619.
    CrossRef
  18. Mullen, Environ. Microbiol. 1989, 55, 3143–3149.
    CrossRef
  19. Klaus,T.; Natl. Acad. Sci.1999, 96, 13611–13614.
    CrossRef
  20. Nair, Growth Des. 2002, 2, 293–298.
    CrossRef
  21. Kalimuthu, Colloid Surface B2008, 65, 150–153.
    CrossRef
  22. Gurunathan, Colloids Surf. B Biointerfaces2009, 74, 328–335.
    CrossRef
  23. Kalishwaralal, Colloids Surf. B Biointerfaces2010, 77, 257–262.
    CrossRef
  24. Gurunathan, S, Nanoscale Res. Lett.2014, 9, 373.
    CrossRef
  25. Thakkar., Nanomedicine2010, 6, 257–262.
    CrossRef
  26. Murdock, R.C., Sci. 2008, 101, 239–253.
    CrossRef
  27. Sapsford, K.E., Chem.2011, 83, 4453–4488.
    CrossRef
  28. Krolikowska., Surf Sci.2003; 532:227-232.
    CrossRef
  29. Zhao G, Biometals. 1998; 11:27.
    CrossRef
  30. Jiang H., J Appl Polym Sci. 2004; 93:1411-1422.
    CrossRef
  31. Okafor F., Int. J. Environ. Res. Public Health. 2013; 10:5221-5238.
    CrossRef
  32. Amarendra DD., Colloid Surface A. 2010; 369(3):27-33.
  33. Pal S L., Journal of Applied Pharmaceutical Science. 2011; 1, 228-234
  34. VJ Mohanraj., Journal of Pharmaceutical Research”. 2006; 5 (1):561-573
  35. Horikoshi S And Serpone N. Introduction to Nanoparticles
  36. Xu., Chemical Engineering Science. 2006; 61:1027-1040.
    CrossRef
  37. M Ramya., J. Pharm. Med. & Bio. Sc. 2012; 1.
  38. Drake., Ann Occup Hyg, 2005; 49:575-585.
  39. Prabhu S., International Nano Letters. 2012; 2:32
    CrossRef
  40. Klaus., Proc Natl Acad Sci USA. 1999; 96:13611-13614.
    CrossRef
  41. Sahayaraj K., Nanoscale Research Letters. 2018 (54); 6-7.
  42. Zhi Zhang., Nanoscale Research Letters. 2018 (54); 6-7.
  43. Sastry, M., Phys. Chem. B1998, 102, 1404–1410.
    CrossRef
  44. Huang., Nanomed. Lond. 2007, 2, 681–693.
    CrossRef
  45. Leung., Appl. Opt. 2006, 45, 2186–2190.
    CrossRef
  46. Tomaszewska., J. Nanomater. 2013, 2013, 313081.
    CrossRef
  47. Link., Rev. Phys. Chem. 2003, 54, 331–366.
    CrossRef
  48. Noginov, M., Phys. B2007, 86, 455–460.
    CrossRef
  49. Nath, S.S., Nano Trends2007, 2, 20–28.
  50. Taleb, A., Phys. Chem. B1998, 102, 2214–2220.
    CrossRef
  51. He, R., Mater. Chem. 2002, 12, 3783–3786.
    CrossRef
  52. Lin, P.C., Adv. 2014, 32, 711–726.
    CrossRef
  53. Shang, L., Langmuir 2007, 23, 2714–2721.
    CrossRef
  54. Perevedentseva., Quantum Electron. 2010, 40, 1089–1093.
    CrossRef
  55. Das, R., Nanotechnol. 2009, 5, 1–6.
  56. Waseda, Springer Verlag: Berlin, Germany, 2011.
  57. Ivanisevic., J. Pharm. Sci. 2010, 99, 4005–4012.
    CrossRef
  58. Cabral., Environ. Technol. 2013, 34, 1283–1295.
    CrossRef
  59. Dey, A., Therm. Spray Technol. 2009, 18, 578–592.
    CrossRef
  60. Ananias, D., Microporous Mesoporous Mater. 2013, 166, 50–58.
    CrossRef
  61. Singh, D.K.; Exp. Nanosci. 2013, 8, 567–577.
  62. Sapsford, K.E., Chem. 2011, 83, 4453–4488.
    CrossRef
  63. Cantor, San Francisco, CA, USA, 1980.
  64. Zawrah, Des. 2013, 46, 485–490.
    CrossRef
  65. Yazdian., Adv. Powder Technol. 2013, 24, 106–112.
    CrossRef
  66. Wu, H., New J. Chem. 2011, 35, 2902–2909.
    CrossRef
  67. Vaia, R.A., J. Polym. Sci. Part B Polym. Phys. 2002, 40, 1590–1600.
    CrossRef
  68. Ray, S.S., Polym. Sci. 2003, 28, 1539–1641.
    CrossRef
  69. Pavlidou, Polym. Sci. 2008, 33, 1119–1198.
    CrossRef
  70. Kou, T., Adv.2012, 2, 12636–12643.
    CrossRef
  71. Khan, A., Part B Eng. 2013, 45, 1486–1492.
    CrossRef
  72. , Powder Technol. 2013, 233, 208–214.
    CrossRef
  73. Aghili, S.E., Manuf. Process. 2012, 27, 1348–1353.
    CrossRef
  74. Das, R., Adv. Mater. Sci. 2014, 38, 95–109.
  75. Pawley., Scanning 1997, 19, 324–336.
  76. Wang, Z.L., Phys. Chem. B2000, 104, 1153–1175.
    CrossRef
  77. Yao, H., Formatex Research Center: Badajoz, Spain, 2007; pp. 568–575.
  78. Joshi., J. Fiber Text. Res. 2008, 33, 304–317.
    CrossRef
  79. Williams., Springer Verlag: New York, NY, USA, 2009.
  80. Hinterdorfer., Acc. Chem. Res.2012, 45, 327–336.
    CrossRef
  81. Koh, A., Ultramicroscopy2008, 108, 1490–1494.
    CrossRef
  82. Mavrocordatos., Water Sci. Technol. 2004, 50, 9–18.
    CrossRef
  83. Picas, L. Chem. Phys. Lipids 2012, 165, 845–860.
    CrossRef
  84. Song., ACS Appl. Mater. Interfaces2013, 5, 11563–11568.
    CrossRef
  85. Sova M., Rev Med Chem. 2012;12(8):749–767.
    CrossRef
  86. Juan., Molecules. 2014; 19:19292–19349.
    CrossRef
Article Publishing History
Received on: 14 May 2025
Accepted on: 22 Nov 2025

Article Review Details
Reviewed by: Dr. Jeeffin Blessikha
Second Review by: Dr. Anandhu C S
Final Approval by: Dr. Ayssar Nahle


Share


Journal is Indexed in

Cabells Whitelist


Journal Archived in: